November 11, 2024

Immunoassay Market Size to Grow US$ 51.33 Billion By 2032

The global immunoassay market size was approximate at US$ 32.46 billion in 2022 and is anticipated to grow US$ 51.33 billion by 2032, registering a compound annual growth rate of 4.68% from 2023 to 2032.

Immunoassay Market Size 2023 To 2032 - Precedence Statistics

The immunoassay market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the immunoassay market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the immunoassay report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the immunoassay market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2557

Immunoassay Market Report Scope 

Report Coverage Details
Market Size in 2023 USD 33.98 Billion
Market Size by 2032 USD 51.33 Billion
Growth Rate from 2023 to 2032 CAGR of 4.68%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Product, By Technology, By Specimen, By Application and By End User

Also read: Sensor Market Size to Grow US$ 508.64 Billion By 2032

Research Approach

The comprehensive report on the global immunoassay market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global immunoassay market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthinners

Immunoassay Market Segmentations

By Product

  • Reagents & Kits
    • ELISA Reagents & Kits
    • Rapid Test Reagent & Kits
    • ELISpot Reagents & Kits
    • Western Blot Reagents & Kits
    • Other Reagents & Kits
  • Analyzer
    • By Type
      • Open-ended System
      • Closed-Ended System
    • By Purchased Mode
      • Rental Purchased
      • Outright Purchased
  • Software and Services

By Technology

  • ELISA
    • By generation
      • Third generation & Above
      • Second-generation & Below
  • Rapid Tests
  • ELISpot
  • Western Blotting
  • Radioimmunoassay
  • Other technologies

By Specimen

  • Blood
  • Saliva
  • Urine
  • Other Specimen

By Application

  • Infectious diseases
  • Endocrinology
  • Oncology
  • Bone and mineral disorders
  • Cardiology
  • Blood screening
  • Autoimmune Disorders
  • Allergy Diagnostics
  • Toxicology
  • Newborn Screening
  • Other Application

By End-User

  • Hospitals & Clinics
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies And Cro
  • Blood Banks
  • Research & Academic Laboratories
  • Home Care Setting

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoassay Market 

5.1. COVID-19 Landscape: Immunoassay Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoassay Market, By Product

8.1. Immunoassay Market, by Product, 2023-2032

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Analyzer

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Software and Services

8.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Immunoassay Market, By Technology

9.1. Immunoassay Market, by Technology, 2023-2032

9.1.1. ELISA

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Rapid Tests

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. ELISpot

9.1.3.1. Market Revenue and Forecast (2023-2032)

9.1.4. Western Blotting

9.1.4.1. Market Revenue and Forecast (2023-2032)

9.1.5. Radioimmunoassay

9.1.5.1. Market Revenue and Forecast (2023-2032)

9.1.6. Other technologies

9.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Immunoassay Market, By Specimen 

10.1. Immunoassay Market, by Specimen, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Saliva

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Urine

10.1.3.1. Market Revenue and Forecast (2023-2032)

10.1.4. Other Specimen

10.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 11. Global Immunoassay Market, By Application

11.1. Immunoassay Market, by Application, 2023-2032

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Endocrinology

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Oncology

11.1.3.1. Market Revenue and Forecast (2023-2032)

11.1.4. Bone and mineral disorders

11.1.4.1. Market Revenue and Forecast (2023-2032)

11.1.5. Cardiology

11.1.5.1. Market Revenue and Forecast (2023-2032)

11.1.6. Blood screening

11.1.6.1. Market Revenue and Forecast (2023-2032)

11.1.7. Autoimmune Disorders

11.1.7.1. Market Revenue and Forecast (2023-2032)

11.1.8. Allergy Diagnostics

11.1.8.1. Market Revenue and Forecast (2023-2032)

11.1.9. Toxicology

11.1.9.1. Market Revenue and Forecast (2023-2032)

11.1.10. Newborn Screening

11.1.10.1. Market Revenue and Forecast (2023-2032)

11.1.11. Other Application

11.1.11.1. Market Revenue and Forecast (2023-2032)

Chapter 12. Global Immunoassay Market, By End-User

12.1. Immunoassay Market, by End-User, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2023-2032)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2023-2032)

12.1.3. Pharmaceutical & Biotechnology Companies And Cro

12.1.3.1. Market Revenue and Forecast (2023-2032)

12.1.4. Blood Banks

12.1.4.1. Market Revenue and Forecast (2023-2032)

12.1.5. Research & Academic Laboratories

12.1.5.1. Market Revenue and Forecast (2023-2032)

12.1.6. Home Care Setting

12.1.6.1. Market Revenue and Forecast (2023-2032)

Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.7.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.7.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.7. Market Revenue and Forecast, by Application (2023-2032)

13.2.8. Market Revenue and Forecast, by End-User (2023-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.9.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.9.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.10. Market Revenue and Forecast, by Application (2023-2032)

13.2.11. Market Revenue and Forecast, by End-User (2023-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.12.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.12.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.13. Market Revenue and Forecast, by End-User (2023-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.14.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.14.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.15. Market Revenue and Forecast, by End-User (2023-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.7. Market Revenue and Forecast, by End-User (2023-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.9. Market Revenue and Forecast, by End-User (2023-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.7. Market Revenue and Forecast, by End-User (2023-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.9. Market Revenue and Forecast, by End-User (2023-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.7. Market Revenue and Forecast, by End-User (2023-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2023-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Beckman Coulter)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Quidel Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ortho Clinical Diagnostics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sysmex Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson, and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Siemens Healthinners

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global immunoassay market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for immunoassay are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

 

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *